NCT07026110Recruiting
Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer
Source: ClinicalTrials.gov · Last updated 18 Jun 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to explore the efficacy of Trop2, EpCAM-specific PET/CT imaging for noninvasive visualization of Trop2 or EpCAM expression levels in non-small cell lung cancer; and to explore the differences between novel target-specific PET/CT examinations and conventional 18F-FDG PET/CT in the diagnosis and differential diagnosis of solid lung nodules.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- First submitted
- 10 Jun 2025
- Start date
- Dec 2024
- Primary completion date
- Oct 2026
- Lead sponsor
- RenJi Hospital
- Diseases
- Lung cancer
- NCT number
- NCT07026110
What you commit to
- Study type: Interventional
- Planned participants: 100
- From Dec 2024 to the primary completion date, Oct 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient has participated in other clinical studies within the past year that have resulted in radiation exposures in excess of an effective dose of 50 mSv, in addition to the radiation exposures anticipated from participation in this clinical study;
Other illness
- Persons with a history of surgery and trauma that significantly affects metabolic distribution and anatomical structure;
- Persons with severe other systemic diseases or known hypersensitivity to humanized monoclonal antibody products;
Other
- Women during pregnancy and lactation;
- Patient is unable to cooperate in completing the PET/CT examination;
- Patient should not participate in this clinical trial in the opinion of the investigator.
Who the study is looking for
- Age 18-80 years;
- Imaging studies suspecting non-small cell lung cancer;
- Solid lung nodules (≥8 mm in diameter) diagnosed by chest ct, which are subject to 18F-FDG PET/CT and surgical resection/biopsy of lung nodules according to the NCCN guideline specifications for NSCLC in the 2024 edition;
- Patients or family members agreed to participate in this clinical study and signed an informed consent form.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Renji Hospital, School of Medicine, Shanghai Jiao Tong University Coordinator of this site? Confirm its status | Shanghai | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.